Copy number loss of KDM5D may be a predictive biomarker for ATR inhibitor treatment in male patients with pulmonary squamous cell carcinoma.

In contrast, CD8 + /T‐bet + T cells infiltrated tumors with KDM5D copy number loss less than wild‐type tumors, but these differences did not reach statistical significance (Figure 3D–F ).

also in 111,027 other papers